"Preferred shares" undergo major changes! Including Amazon.com, Inc. (AMZN.US), AppLovin (APP.US), and McDonald's Corporation (MCD.US), focusing on AI infrastructure and consumption.

date
21:40 18/05/2026
avatar
GMT Eight
On Monday, Jefferies made adjustments to its "Franchise Picks" list, adding names such as Amazon, AppLovin, and Credo Technology.
Wall Street financial giant Jefferies Financial Group Inc. (Jefferies) adjusted its "Franchise Picks" list in a research report released on Monday. The investment bank's stock team added Amazon.com, Inc. (AMZN.US), AppLovin (APP.US), Credo Technology (CRDO.US), McDonald's Corporation (MCD.US), RadNet (RDNT.US), Thermo Fisher Scientific Inc. (TMO.US), and UL Solutions (ULS.US) to the list. In addition, recent additions include American Healthcare Realty Trust Incorporated Class A (AHR.US) and Ovintiv (OVV.US). At the same time, AIG (AIG.US), Broadcom Inc. (AVGO.US), First Capital, Inc. (COF.US), Expand Energy (EXE.US), GFL Environmental (GFL.US), NIKE, Inc. Class B (NKE.US), and Snowflake (SNOW.US) were removed from the list. The new targets mainly focus on leaders in AI computing infrastructure, digital advertising, healthcare demand, and core consumer value areas. Jefferies pointed out that with the gradual ramp-up of computing power and AI partnerships boosting long-term revenue visibility, Amazon.com, Inc.'s AWS business is in the early stages of reacceleration. AppLovin is seen as a leading platform in the mobile gaming advertising sector, and its direct e-commerce business is also growing steadily. The inclusion of Credo Technology is based on the market's early expectations for active electrical cable (AEC) penetration rate, which is expected to support its continued growth through 2028 and beyond. Regarding McDonald's Corporation, Jefferies expects that its refreshed "McValue" value platform will support same-store sales growth and market share gains, even though short-term expectations are relatively flat. RadNet benefits from the growth in PET, MRI, and CT scan demand, and Jefferies is optimistic about the outlook for outpatient imaging demand. Thermo Fisher is hoped to see improvement in the biopharmaceutical industry growth in the second half of 2026, leading to a profit turning point. As a leader in the global Testing, Inspection, and Certification (TIC) industry, UL Solutions has been added due to its pricing power, macro risk resistance, and potential AI-related testing demand. Jefferies believes the company's guidance for fiscal year 2026 may be conservative. Jefferies stated that their "Franchise Picks" list covers the firm's most confident "buy" rated U.S. market research subjects, supported by differentiated analysis, catalyst factors, and valuation-driven upside potential. The complete list is as follows: [list not provided]